Food News and Research

RSS

New findings could help develop therapeutic options for glycogen storage disease

Glycogen storage disorders, which affect the body's ability to process sugar and store energy, are rare metabolic conditions that frequently manifest in the first years of life. Often accompanied by liver and muscle disease, this inability to process and store glucose can have many different causes, and can be difficult to diagnose.

11 Nov 2014

ViewRay's MRIdian system gets CE Mark approval

ViewRay, a privately held medical device company, announced today that its MRIdian (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, has received CE Mark (Conformite Europeenne) approval.

11 Nov 2014

Five simple steps to reduce type-2 diabetes

There are 29 million U.S. adults diagnosed with diabetes and an additional 1 in 3 diagnosed as pre-diabetic. Diabetes is a serious disease which can result in serious health complications including nerve damage, vision loss, heart disease, and kidney failure, to name a few.

11 Nov 2014

FDA accepts Amgen's evolocumab BLA for review

Amgen today announced that the U.S. Food and Drug Administration has accepted for review Amgen's Biologics License Application (BLA) for evolocumab for the treatment of high cholesterol.

11 Nov 2014

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

11 Nov 2014

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.

11 Nov 2014

Innovative program benefits incapacitated patients with no family or friends

A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.

11 Nov 2014

Obese children face increased risk of becoming obese in teen years

Children who are overweight or obese by fifth grade have a high risk of becoming or remaining obese in their teen years, according to a study by researchers from Boston Children's Hospital and elsewhere.

10 Nov 2014

FDA approves ImThera Medical's investigational device exemption for pivotal study

ImThera Medical, Inc., a privately held global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study.

10 Nov 2014

SQI Diagnostics gets FDA clearance to market Celiac Panel in the US

SQI Diagnostics Inc. today announced that it has received notice that the United States Food and Drug Administration has cleared the Company to market its proprietary Celiac Panel in the United States (US).

8 Nov 2014

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Laparoscopic gastric bypass surgery in patients with type 2 diabetes, once considered a high-risk procedure, carries a complication and mortality rate comparable to some of the safest and most commonly performed surgeries in America, including gallbladder surgery, appendectomy, and total knee replacement, according to new research from the Cleveland Clinic Bariatric and Metabolic Institute.

7 Nov 2014

Health benefits of modified formulation of curcumin supplements

The health benefits of over-the-counter curcumin supplements might not get past your gut, but new research shows that a modified formulation of the spice releases its anti-inflammatory goodness throughout the body.

7 Nov 2014

School lunches have greater nutritional quality than packed lunches

Approximately 60% of the more than 50 million public elementary and secondary education students obtain a substantial portion of their daily calories from school lunches. The 2012-2013 National School Lunch Program (NSLP) nutritional standards govern what those students eat; for those who bring packed lunches, there are no nutritional standards, however.

7 Nov 2014

Seattle Children's starts patient enrollment for immunotherapy clinical trial for neuroblastoma

Seattle Children's today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, one of the deadliest forms of childhood cancer.

7 Nov 2014

Ipsen receives approval from FDA for new device designed to deliver Somatuline Depot Injection

Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.

7 Nov 2014

New wearable device can automatically track diet

Sensors and software used to track physical activity are increasingly popular, as smart phones and their apps become more powerful and sophisticated, but, when it comes to food, they all rely on the user to report meals.

7 Nov 2014

MMRF initiative aims to speed up evaluation of new investigational drugs for multiple myeloma

The Multiple Myeloma Research Foundation today announced an initiative designed to accelerate the evaluation of new investigational therapies for multiple myeloma (MM).

6 Nov 2014

NIH boosts funding for first large-scale clinical trial aimed at identifying drugs for Alzheimer's

The National Institutes of Health has boosted funding for the first large-scale clinical trial aimed at identifying drugs to stop or slow Alzheimer's disease in people destined to get the debilitating illness.

6 Nov 2014

Impax announces submission of EMA Marketing Authorization Application for IPX066

Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.

6 Nov 2014

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

Janssen Research & Development, LLC today announced a collaboration with the International Union Against Tuberculosis and Lung Disease (The Union) to include SIRTURO (bedaquiline) in the STREAM Study.

6 Nov 2014

Food News and Research

New findings could help develop therapeutic options for glycogen storage disease

ViewRay's MRIdian system gets CE Mark approval

Five simple steps to reduce type-2 diabetes

FDA accepts Amgen's evolocumab BLA for review

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

Innovative program benefits incapacitated patients with no family or friends

Obese children face increased risk of becoming obese in teen years

FDA approves ImThera Medical's investigational device exemption for pivotal study

SQI Diagnostics gets FDA clearance to market Celiac Panel in the US

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Health benefits of modified formulation of curcumin supplements

School lunches have greater nutritional quality than packed lunches

Seattle Children's starts patient enrollment for immunotherapy clinical trial for neuroblastoma

Ipsen receives approval from FDA for new device designed to deliver Somatuline Depot Injection

New wearable device can automatically track diet

MMRF initiative aims to speed up evaluation of new investigational drugs for multiple myeloma

NIH boosts funding for first large-scale clinical trial aimed at identifying drugs for Alzheimer's

Impax announces submission of EMA Marketing Authorization Application for IPX066

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

The future is bioengineered: Synthetic biology and global sustainability eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News